Catalyst Watch: Tesla's Robotaxi Reveal, AI Events for Nvidia, AMD, and HP Enterprise
Capricor Stock Rallies 20% on DMD Data Presentation Update
Exelixis Analyst Ratings
Peeling Back The Layers: Exploring Gilead Sciences Through Analyst Insights
Gilead Sciences Analyst Ratings
Shares of US-listed Chinese Stocks Are Trading Higher as the Sector Rebounds Following Thursday's Selloff. Strength May Be Due to the Recent Stimulus Package and the Golden Week Holidays.
Wells Fargo's 'Value Equity' Stocks: VZ, AZO, KR, and More
Dianthus Started at Outperform by Oppenheimer on DNTH103 Opportunity
Dr. Reddy's Signs Voluntary Licensing Agreement With Gilead Sciences To Manufacture And Commercialise Lenacapavir In India And Other Countries
Gilead Signs Deals With Six Drugmakers for Generic Lenacapavir
Today's Pre-Market Movers and Top Ratings | LI, BABA, NKE and More
Express News | Hedge Funds Are Pouring Into ETFs Focusing on Chinese Equities With $2.4 Billion Inflows
$1000 Invested In This Stock 20 Years Ago Would Be Worth $8,800 Today
Capital Markets' Top 30 Global Ideas for the Fourth Quarter
BioNTech's InstaDeep Unit Showcases AI Breakthroughs in Vaccines and Cancer Treatments
How to Capitalize on the Ongoing Bull Market for Chinese Stocks
Stocks With the Highest Consensus of Expected ROE Growth, Goldman Sachs Says
Novo Nordisk's Ozempic, Regeneron/Sanofi's Dupixent Set to Advance in Top Drug Sales
Here Are the Medicare Part D Drugs Expected to Face 2025 Price Negotiations
Exact Sciences, Quanterix Extend Slide After Medicare Rates